NBI-6024

· Neurocrine Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NBI-6024, covering 2009-04-01 to 2009-04-01. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate NBI-6024 in Adult and Adolescent Patients With New Onset of Type 1 Diabetes Mellitus [Phase 1]

See pricing